Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine
Pitfalls, and Genetic Features of Children with 46,XY DSD

Objective: Androgen insensivity syndrome (AIS) and 5α-reductase deficiency (5α-RD) present with indistinguishable phenotypes among the 46,XY disorders of sexual development (DSD) that usually necessitate molecular analyses for the definitive diagnosis in the prepubertal period. The aim was to evaluate the clinical, hormonal and genetic findings of 46,XY DSD patients who were diagnosed as AIS or 5α-RD. Methods: Patients diagnosed as AIS or 5α-RD according to clinical and hormonal evaluations were investigated. Sequence variants of steroid 5-α-reductase type 2 were analyzed in cases with testosterone/dihydrotestosterone (T/DHT) ratio of ≥20, whereas the androgen receptor (AR) gene was screened when the ratio was <20. Stepwise analysis of other associated genes were screened in cases with no causative variant found in initial analysis. For statistical comparisons, the group was divided into three main groups and subgroups according to their genetic diagnosis and T/DHT ratios. Results: A total of 128 DSD patients from 125 non-related families were enrolled. Birth weight SDS and gestational weeks were significantly higher in 5α-RD group than in AIS and undiagnosed groups. Completely female phenotype was higher in all subgroups of both AIS and 5α-RD patients than in the undiagnosed subgroups. In those patients with stimulated T/DHT <20 in the prepubertal period, stimulated T/DHT ratio was significantly lower in AIS than in the undiagnosed group, and higher in 5α-RD. Phenotype associated variants were detected in 24% (n=18 AIS, n=14 5α-RD) of the patients, revealing four novel AR variants (c.94G>T, p.Glu32*, c.330G>C, p.Leu110=; c.2084C>T, p.Pro695Leu, c.2585_2592delAGCTCCTG, p.(Lys862Argfs*16), of these c.330G>C with silent status remained undefined in terms of its causative effects. Conclusion: T/DHT ratio is an important hormonal criterion, but in some cases, T/DHT ratio may lead to diagnostic confusion. Molecular diagnosis is important for the robust diagnosis of 46,XY DSD patients. Four novel AR variants were identified in our study.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Pang S, Levine LS, Chow D, Sagiani F, Saenger P, New MI. Dihydrotestosterone and its relationship to testosterone in infancy and childhood. J Clin Endocrinol Metab 1979;48:821-826.
2. Akcay T, Fernandez-Cancio M, Turan S, Güran T, Audi L, Bereket A. AR and SRD5A2 gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity. Andrology 2014;2:572-578. Epub 2014 Apr 16
3. Audi L, Fernández-Cancio M, Carrascosa A, Andaluz P, Torán N, Piró C, Vilaró E, Vicens-Calvet E, Gussinyé M, Albisu MA, Yeste D, Clemente M, Hernández de la Calle I, Del Campo M, Vendrell T, Blanco A, Martínez- Mora J, Granada ML, Salinas I, Forn J, Calaf J, Angerri O, Martínez-Sopena MJ, Del Valle J, García E, Gracia-Bouthelier R, Lapunzina P, Mayayo E, Labarta JI, Lledó G, Sánchez Del Pozo J, Arroyo J, Pérez-Aytes A, Beneyto M, Segura A, Borrás V, Gabau E, Caimarí M, Rodríguez A, Martínez-Aedo MJ, Carrera M, Castaño L, Andrade M, Bermúdez de la Vega JA; Grupo de Apoyo al Síndrome de Insensibilidad a los Andrógenos (GrApSIA). Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development. J Clin Endocrinol Metab 2010;95:1876-1888. Epub 2010 Feb 11
4. Fernández-Cancio M, Audí L, Andaluz P, Torán N, Piró C, Albisu M, Gussinyé M, Yeste D, Clemente M, Martínez-Mora J, Blanco A, Granada ML, Marco M, Ferragut J, López-Siguero JP, Beneyto M, Carles C, Carrascosa A. SRD5A2 gene mutations and polymorphisms in Spanish 46,XY patients with a disorder of sex differentiation. Int J Androl 2011;34:526-535. Epub 2011 Jun 2
5. Batista RL, Costa EMF, Rodrigues AS, Gomes NL, Faria JA Jr, Nishi MY, Arnhold IJP, Domenice S, Mendonca BB. Androgen insensitivity syndrome: a review. Arch Endocrinol Metab 2018;62:227-235.
6. Liu Q, Yin X, Li P. Clinical, hormonal and genetic characteristics of androgen insensitivity syndrome in 39 Chinese patients. Reprod Biol Endocrinol 2020;18:34.
7. Ono M, Harley VR. Disorders of sex development: new genes, new concepts. Nat Rev Endocrinol 2013;9:79-91. Epub 2012 Dec 18
8. Carmichael SL, Witte JS, Ma C, Lammer EJ, Shaw GM. Hypospadias and variants in genes related to sex hormone biosynthesis and metabolism. Andrology 2014;2:130-137. Epub 2013 Nov 26
9. Peters M, Saare M, Kaart T, Haller-Kikkatalo K, Lend AK, Punab M, Metspalu A, Salumets A. Analysis of polymorphisms in the SRD5A2 gene and semen parameters in Estonian men. J Androl 2010;31:372- 378. Epub 2009 Nov 19
10. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995;16:271-321.
11. Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. BJU Int 2000;85:120-124.
12. Ahmed SF, Achermann JC, Arlt W, Balen A, Conway G, Edwards Z, Elford S, Hughes IA, Izatt L, Krone N, Miles H, O’Toole S, Perry L, Sanders C, Simmonds M, Watt A, Willis D. Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015). Clin Endocrinol (Oxf) 2016;84:771-788. Epub 2015 Aug 13
13. Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, Bas F. Growth references for Turkish children aged 6 to 18 years. Acta Paediatr 2006;95:1635-1641.
14. Telatar B, Comert S, Vitrinel A, Erginöz E. Anthropometric measurements of term neonates from a state hospital in Turkey. East Mediterr Health J 2009;15:1412-1419.
15. Chan YM, Levitsky LL, Baskin LS, Geffner ME, Hoppin AG. Evaluation of the infants with atypical genitalia (disorder of sex development). 2019 UpToDate, www.uptodate.com. Available from: https://www. uptodate.com/contents/evaluation-of-the-infant-with-atypical-genitalappearance- difference-of-sex-development
16. Cox K, Bryce J, Jiang J, Rodie M, Sinnott R, Alkhawari M, Arlt W, Audi L, Balsamo A, Bertelloni S, Cools M, Darendeliler F, Drop S, Ellaithi M, Guran T, Hiort O, Holterhus PM, Hughes I, Krone N, Lisa L, Morel Y, Soder O, Wieacker P, Ahmed SF. Novel associations in disorders of sex development: findings from the I-DSD Registry. J Clin Endocrinol Metab 2014;99:348-355. Epub 2013 Dec 3
17. Topcu V, Ilgin-Ruhi H, Siklar Z, Karabulut HG, Berberoglu M, Hacihamdioglu B, Savas-Erdeve S, Aycan Z, Peltek-Kendirci HN, Ocal G, Tukun FA. Investigation of androgen receptor gene mutations in a series of 21 patients with 46,XY disorders of sex development. J Pediatr Endocrinol Metab 2015;28:1257-1263.
18. Bertelloni S, Russo G, Baroncelli GI. Human Chorionic Gonadotropin Test: Old Uncertainties, New Perspectives, and Value in 46,XY Disorders of Sex Development. Sex Dev 2018;12:41-49. Epub 2017 Nov 2
19. Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Jang W, Karapetyan K, Katz K, Liu C, Maddipatla Z, Malheiro A, McDaniel K, Ovetsky M, Riley G, Zhou G, Holmes JB, Kattman BL, Maglott DR. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res 2018;46:1062-1067.
20. Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 2017;136:665-677. Epub 2017 Mar 27
21. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-424. Epub 2015 Mar 5
22. Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009;37:e67. Epub 2009 Apr 1 23. Kotlar D, Lavner Y. The action of selection on codon bias in the human genome is related to frequency, complexity, and chronology of amino acids. BMC Genomics 2006;7:67.
24. Baetens D, Mladenov W, Delle Chiaie B, Menten B, Desloovere A, Iotova V, Callewaert B, Van Laecke E, Hoebeke P, De Baere E, Cools M. Extensive clinical, hormonal and genetic screening in a large consecutive series of 46,XY neonates and infants with atypical sexual development. Orphanet J Rare Dis 2014;9:209.
25. Ittiwut C, Pratuangdejkul J, Supornsilchai V, Muensri S, Hiranras Y, Sahakitrungruang T, Watcharasindhu S, Suphapeetiporn K, Shotelersuk V. Novel mutations of the SRD5A2 and AR genes in Thai patients with 46, XY disorders of sex development. J Pediatr Endocrinol Metab 2017;30:19-26.
26. Ahmadifard M, Kajbafzadeh A, Panjeh-Shahi S, Vand-Rajabpour F, Ahmadi-Beni R, Arshadi H, Setoodeh A, Rostami P, Tavakkoly-Bazzaz J, Tabrizi M. Molecular investigation of mutations in androgen receptor and 5-alpha-reductase-2 genes in 46,XY Disorders of Sex Development with normal testicular development. Andrologia 2019;51:e13250. Epub 2019 Feb 27
27. Diaz A, Lipman Diaz EG. Disorders of Sex Development. Pediatr Rev 2021;42:414-426.
28. Ata A, Özen S, Onay H, Uzun S, Gökşen D, Özkınay F, Özbaran NB, Ulman İ, Darcan Ş. A large cohort of disorders of sex development and their genetic characteristics: 6 novel mutations in known genes. Eur J Med Genet 2021;64:104154. Epub 2021 Jan 29
29. Délot EC, Papp JC; DSD-TRN Genetics Workgroup, Sandberg DE, Vilain E. Genetics of Disorders of Sex Development: The DSD-TRN Experience. Endocrinol Metab Clin North Am 2017;46:519-537. Epub 2017 Mar 28
30. Joshi RR, Rao S, Desai M. Etiology and clinical profile of ambiguous genitalia an overview of 10 years experience. Indian Pediatr 2006;43:974-979.
31. Al-Agha AE, Thomsett MJ, Batch JA. The child of uncertain sex: 17 years of experience. J Paediatr Child Health 2001;37:348-351.
32. Poyrazoglu S, Darendeliler F, Ahmed SF, Hughes I, Bryce J, Jiang J, Rodie M, Hiort O, Hannema SE, Bertelloni S, Lisa L, Guran T, Cools M, Desloovere A, Claahsen-van der Grinten HL, Nordenstrom A, Holterhus PM, Kohler B, Niedziela M, Krone N. Birth Weight in Different Etiologies of Disorders of Sex Development. J Clin Endocrinol Metab 2017;102:1044-1050.
33. Ghirri P, Scaramuzzo RT, Bertelloni S, Pardi D, Celandroni A, Cocchi G, Danieli R, De Santis L, Di Stefano MC, Gerola O, Giuffrè M, Gragnani GS, Magnani C, Meossi C, Merusi I, Sabatino G, Tumini S, Corsello G, Boldrini A. Prevalence of hypospadias in Italy according to severity, gestational age and birthweight: an epidemiological study. Ital J Pediatr 2009;35:18.
34. Yinon Y, Kingdom JC, Proctor LK, Kelly EN, Salle JL, Wherrett D, Keating S, Nevo O, Chitayat D. Hypospadias in males with intrauterine growth restriction due to placental insufficiency: the placental role in the embryogenesis of male external genitalia. Am J Med Genet A 2010;152A:75-83.
35. Scaramuzzo RT, Boldrini A, Bertelloni S, Parrini D, Serino L, Ghirri P. Low testosterone levels in pre-term newborns born small for gestational age. J Endocrinol Invest 2010;33:215-217. Epub 2010 May 5
36. Huisma F, Thomas M, Armstrong L. Severe hypospadias and its association with maternal-placental factors. Am J Med Genet A 2013;161:2183-2187. Epub 2013 Aug 2
37. Deeb A, Mason C, Lee YS, Hughes IA. Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome. Clin Endocrinol (Oxf) 2005;63:56-62.
38. Su R, Adam MP, Ramsdell L, Fechner PY, Shnorhavorian M. Can the external masculinization score predict the success of genetic testing in 46,XY DSD? AIMS Genetics 2015;2:163-172.
39. Veiga-Junior NN, Medaets PA, Petroli RJ, Calais FL, de Mello MP, Castro CC, Guaragna-Filho G, Sewaybricker LE, Marques-de-Faria AP, Maciel- Guerra AT, Guerra-Junior G. Clinical and Laboratorial Features That May Differentiate 46,XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency. Int J Endocrinol 2012;2012:964876. Epub 2011 Dec 12
40. Cheng J, Lin R, Zhang W, Liu G, Sheng H, Li X, Zhou Z, Mao X, Liu L. Phenotype and molecular characteristics in 45 Chinese children with 5α-reductase type 2 deficiency from South China. Clin Endocrinol (Oxf) 2015;83:518-526. Epub 2015 May 7
41. Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P, Fenichel P, Cartigny M, Pienkowski C, Polak M, Skordis N, Mazen I, Ocal G, Berberoglu M, Reynaud R, Baumann C, Cabrol S, Simon D, Kayemba- Kay’s K, De Kerdanet M, Kurtz F, Leheup B, Heinrichs C, Tenoutasse S, Van Vliet G, Grüters A, Eunice M, Ammini AC, Hafez M, Hochberg Z, Einaudi S, Al Mawlawi H, Nuñez CJ, Servant N, Lumbroso S, Paris F, Sultan C. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab 2011;96:296-307. Epub 2010 Dec 8
42. Shabir I, Khurana ML, Joseph AA, Eunice M, Mehta M, Ammini AC. Phenotype, genotype and gender identity in a large cohort of patients from India with 5α-reductase 2 deficiency. Andrology 2015;3:1132-1139. 43. Atta I, Ibrahim M, Parkash A, Lone SW, Khan YN, Raza J. Etiological diagnosis of undervirilized male/XY disorder of sex development. J Coll Physicians Surg Pak 2014;24:714-718.
44. Lee YS, Cheng AW, Ahmed SF, Shaw NJ, Hughes IA. Genital anomalies in Klinefelter’s syndrome. Horm Res 2007;68:150-155. Epub 2007 Jul 19
45. Jääskeläinen J. Molecular biology of androgen insensitivity. Mol Cell Endocrinol 2012;352:4-12. Epub 2011 Aug 17
46. Avendaño A, Paradisi I, Cammarata-Scalisi F, Callea M. 5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review. Hormones (Athens) 2018;17:197-204. Epub 2018 Apr 20
47. Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M. The androgen receptor gene mutations database: 2012 update. Hum Mutat 2012;33:887-894. Epub 2012 Mar 13
48. Hornig NC, Rodens P, Dörr H, Hubner NC, Kulle AE, Schweikert HU, Welzel M, Bens S, Hiort O, Werner R, Gonzalves S, Eckstein AK, Cools M, Verrijn-Stuart A, Stunnenberg HG, Siebert R, Ammerpohl O, Holterhus PM. Epigenetic Repression of Androgen Receptor Transcription in Mutation-Negative Androgen Insensitivity Syndrome (AIS Type II). J Clin Endocrinol Metab 2018;103:4617-4627.
49. Batista RL, Mendonca BB. Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide. Appl Clin Genet 2020;13:83-96.
50. Ulbright TM, Young RH. Gonadoblastoma and selected other aspects of gonadal pathology in young patients with disorders of sex development. Semin Diagn Pathol 2014;31:427-440. Epub 2014 Jul 18
51. Bhangoo A, Paris F, Philibert P, Audran F, Ten S, Sultan C. Isolated micropenis reveals partial androgen insensitivity syndrome confirmed by molecular analysis. Asian J Androl 2010;12:561-566.
52. Zhang T, Karsh LI, Nissenblatt MJ, Canfield SE. Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer. Clin Genitourin Cancer 2020;18:1-10. Epub 2019 Sep 26
53. Elfferich P, van Royen ME, van de Wijngaart DJ, Trapman J, Drop SL, van den Akker EL, Lusher SJ, Bosch R, Bunch T, Hughes IA, Houtsmuller AB, Cools M, Faradz SM, Bisschop PH, Bunck MC, Oostdijk W, Brüggenwirth HT, Brinkmann AO. Variable loss of functional activities of androgen receptor mutants in patients with androgen insensitivity syndrome. Sex Dev 2013;7:223-234.
54. Chávez B, Méndez JP, Ulloa-Aguirre A, Larrea F, Vilchis F. Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome. J Hum Genet. 2001;46:560-565.
55. Melo KF, Latronico AC, Costa EM, Billerbeck AE, Mendonca BB, Arnhold IJ. A novel point mutation (R840S) in the androgen receptor in a Brazilian family with partial androgen insensitivity syndrome. Hum Mutat 1999;14:353.
56. Gottlieb B, Vasiliou DM, Lumbroso R, Beitel LK, Pinsky L, Trifiro MA. Analysis of exon 1 mutations in the androgen receptor gene. Hum Mutat 1999;14:527-539.
57. Thigpen AE, Davis DL, Milatovich A, Mendonca BB, Imperato-McGinley J, Griffin JE, Francke U, Wilson JD, Russell DW. Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 1992;90:799-809.
58. Savas Erdeve S, Aycan Z, Berberoglu M, Siklar Z, Hacihamdioglu B, Sipahi K, Akar N, Ocal G. A novel mutation of 5alpha-steroid reductase 2 deficiency (CD 65 ALA-PRO) with severe virilization defect in a Turkish family and difficulty in gender assignment. Eur J Pediatr 2010;169:991-995.
59. Gui B, Song Y, Su Z, Luo FH, Chen L, Wang X, Chen R, Yang Y, Wang J, Zhao X, Fan L, Liu X, Wang Y, Chen S, Gong C. New insights into 5α-reductase type 2 deficiency based on a multi-centre study: regional distribution and genotype-phenotype profiling of SRD5A2 in 190 Chinese patients. J Med Genet 2019;56:685-692.
60. Di Marco C, Bulotta AL, Varetti C, Dosa L, Michelucci A, Baldinotti F, Meucci D, Castagnini C, Lo Rizzo C, Di Maggio G, Simi P, Mari F, Bertelloni S, Renieri A, Messina M. Ambiguous external genitalia due to defect of 5-α-reductase in seven Iraqi patients: prevalence of a novel mutation. Gene 2013;526:490-493.
61. Boudon C, Lobaccaro JM, Lumbroso S, Ogur G, Ocal G, Belon C, Sultan C. A new deletion of the 5 alpha-reductase type 2 gene in a Turkish family with 5 alpha-reductase deficiency. Clin Endocrinol (Oxf) 1995;43:183-188.
62. Nicoletti A, Baldazzi L, Balsamo A, Barp L, Pirazzoli P, Gennari M, Radetti G, Cacciari E, Cicognani A. SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects. Clin Endocrinol (Oxf) 2005;63:375-380.
63. Can S, Zhu YS, Cai LQ, Ling Q, Katz MD, Akgun S, Shackleton CH, Imperato-McGinley J. The identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred. J Clin Endocrinol Metab 1998;83:560-569.

APA	Bas F, Uyguner Z, Altunoglu U, Toksoy G, Karaman B, Avcı Ş, Yavaş Abalı Z, Poyrazoglu S, Aghayev A, KARAMAN V, Bundak R, Başaran S, Darendeliler F (2022). Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD. , 153 - 171. 10.4274/jcrpe.galenos.2022.2021-9-19
Chicago	Bas Firdevs,Uyguner Zehra Oya,Altunoglu Umut,Toksoy Güven,Karaman Birsen,Avcı Şahin,Yavaş Abalı Zehra,Poyrazoglu Sukran,Aghayev Agharza,KARAMAN VOLKAN,Bundak Ruveyde,Başaran Seher,Darendeliler Feyza Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD. (2022): 153 - 171. 10.4274/jcrpe.galenos.2022.2021-9-19
MLA	Bas Firdevs,Uyguner Zehra Oya,Altunoglu Umut,Toksoy Güven,Karaman Birsen,Avcı Şahin,Yavaş Abalı Zehra,Poyrazoglu Sukran,Aghayev Agharza,KARAMAN VOLKAN,Bundak Ruveyde,Başaran Seher,Darendeliler Feyza Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD. , 2022, ss.153 - 171. 10.4274/jcrpe.galenos.2022.2021-9-19
AMA	Bas F,Uyguner Z,Altunoglu U,Toksoy G,Karaman B,Avcı Ş,Yavaş Abalı Z,Poyrazoglu S,Aghayev A,KARAMAN V,Bundak R,Başaran S,Darendeliler F Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD. . 2022; 153 - 171. 10.4274/jcrpe.galenos.2022.2021-9-19
Vancouver	Bas F,Uyguner Z,Altunoglu U,Toksoy G,Karaman B,Avcı Ş,Yavaş Abalı Z,Poyrazoglu S,Aghayev A,KARAMAN V,Bundak R,Başaran S,Darendeliler F Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD. . 2022; 153 - 171. 10.4274/jcrpe.galenos.2022.2021-9-19
IEEE	Bas F,Uyguner Z,Altunoglu U,Toksoy G,Karaman B,Avcı Ş,Yavaş Abalı Z,Poyrazoglu S,Aghayev A,KARAMAN V,Bundak R,Başaran S,Darendeliler F "Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD." , ss.153 - 171, 2022. 10.4274/jcrpe.galenos.2022.2021-9-19
ISNAD	Bas, Firdevs vd. "Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD". (2022), 153-171. https://doi.org/10.4274/jcrpe.galenos.2022.2021-9-19

APA	Bas F, Uyguner Z, Altunoglu U, Toksoy G, Karaman B, Avcı Ş, Yavaş Abalı Z, Poyrazoglu S, Aghayev A, KARAMAN V, Bundak R, Başaran S, Darendeliler F (2022). Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD. Journal of Clinical Research in Pediatric Endocrinology, 14(2), 153 - 171. 10.4274/jcrpe.galenos.2022.2021-9-19
Chicago	Bas Firdevs,Uyguner Zehra Oya,Altunoglu Umut,Toksoy Güven,Karaman Birsen,Avcı Şahin,Yavaş Abalı Zehra,Poyrazoglu Sukran,Aghayev Agharza,KARAMAN VOLKAN,Bundak Ruveyde,Başaran Seher,Darendeliler Feyza Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD. Journal of Clinical Research in Pediatric Endocrinology 14, no.2 (2022): 153 - 171. 10.4274/jcrpe.galenos.2022.2021-9-19
MLA	Bas Firdevs,Uyguner Zehra Oya,Altunoglu Umut,Toksoy Güven,Karaman Birsen,Avcı Şahin,Yavaş Abalı Zehra,Poyrazoglu Sukran,Aghayev Agharza,KARAMAN VOLKAN,Bundak Ruveyde,Başaran Seher,Darendeliler Feyza Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD. Journal of Clinical Research in Pediatric Endocrinology, vol.14, no.2, 2022, ss.153 - 171. 10.4274/jcrpe.galenos.2022.2021-9-19
AMA	Bas F,Uyguner Z,Altunoglu U,Toksoy G,Karaman B,Avcı Ş,Yavaş Abalı Z,Poyrazoglu S,Aghayev A,KARAMAN V,Bundak R,Başaran S,Darendeliler F Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD. Journal of Clinical Research in Pediatric Endocrinology. 2022; 14(2): 153 - 171. 10.4274/jcrpe.galenos.2022.2021-9-19
Vancouver	Bas F,Uyguner Z,Altunoglu U,Toksoy G,Karaman B,Avcı Ş,Yavaş Abalı Z,Poyrazoglu S,Aghayev A,KARAMAN V,Bundak R,Başaran S,Darendeliler F Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD. Journal of Clinical Research in Pediatric Endocrinology. 2022; 14(2): 153 - 171. 10.4274/jcrpe.galenos.2022.2021-9-19
IEEE	Bas F,Uyguner Z,Altunoglu U,Toksoy G,Karaman B,Avcı Ş,Yavaş Abalı Z,Poyrazoglu S,Aghayev A,KARAMAN V,Bundak R,Başaran S,Darendeliler F "Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD." Journal of Clinical Research in Pediatric Endocrinology, 14, ss.153 - 171, 2022. 10.4274/jcrpe.galenos.2022.2021-9-19
ISNAD	Bas, Firdevs vd. "Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD". Journal of Clinical Research in Pediatric Endocrinology 14/2 (2022), 153-171. https://doi.org/10.4274/jcrpe.galenos.2022.2021-9-19